CATNAP: a tool to compile, analyze and tally neutralizing antibody panels
about
Cross-Neutralizing Antibodies in HIV-1 Individuals Infected by Subtypes B, F1, C or the B/Bbr Variant in Relation to the Genetics and Biochemical Characteristics of the env GeneAntibody 10-1074 suppresses viremia in HIV-1-infected individualsStructural Analysis of the Glycosylated Intact HIV-1 gp120-b12 Antibody Complex Using Hydroxyl Radical Protein Footprinting.Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments.Comprehensive Cross-Clade Characterization of Antibody-Mediated Recognition, Complement-Mediated Lysis, and Cell-Mediated Cytotoxicity of HIV-1 Envelope-Specific Antibodies toward Eradication of the HIV-1 Reservoir.Engineering broadly neutralizing antibodies for HIV prevention and therapy.Determinants of HIV-1 broadly neutralizing antibody induction.Further Characterization of the Bifunctional HIV Entry Inhibitor sCD4-FIT45.Maternal but Not Infant Anti-HIV-1 Neutralizing Antibody Response Associates with Enhanced Transmission and Infant Morbidity.Conserved HIV Epitopes for an Effective HIV Vaccine.Prediction of HIV-1 sensitivity to broadly neutralizing antibodies shows a trend towards resistance over time.Fitness landscape of the human immunodeficiency virus envelope protein that is targeted by antibodies.Identification of novel structural determinants in MW965 Env that regulate the neutralization phenotype and conformational masking potential of primary HIV-1 isolates.Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma.Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 Infection.Functional Relevance of Improbable Antibody Mutations for HIV Broadly Neutralizing Antibody Development.Broadly neutralizing antibodies: What is needed to move from a rare event in HIV-1 infection to vaccine efficacy?Diverse pathways of escape from all well-characterized VRC01-class broadly neutralizing HIV-1 antibodiesHIV Entry and Its Inhibition by Bifunctional Antiviral Proteins
P2860
Q28554907-4449CA10-725B-4B8A-A5B0-016E2BB24874Q33786443-B778B603-5B01-4176-8CE3-09581A4D3338Q37656791-7F611F1B-90B4-4511-87C9-6044D65D3433Q38659318-C351C3AC-6E2B-4521-895B-61E05BCBC759Q38673539-5DC92B40-581F-4544-A99D-4E9B4BDCCECDQ38717198-B55EFE6A-4C24-43D9-9EEA-6186D0F9DC83Q40476608-C07EACEC-7FA5-4A7D-90AA-B26BA37FB248Q42264980-7E0E692D-40C8-47C2-940B-10F077BDE62DQ42638889-2A36D339-A09B-45B7-AA62-F7152CFE21E3Q47093684-ACDAD3D9-D899-4C05-96F8-5A8E147CAC34Q47136810-C5836507-213A-4EEF-A0E5-744E73073EE8Q47193141-65477D7E-9C0B-444E-B83B-F4A669993C12Q47566053-94843C71-D05C-4D0C-89CB-34748CB32B5EQ52577900-46022E23-FC07-4109-8F9D-BD0661B2009AQ55347049-0D3BA51C-5743-4AF8-B75D-94E3D5C49074Q55356257-59B871A0-2D45-4900-A32D-06AF5C770717Q56974226-F782906D-EBC9-4DAE-A88E-DAA80E4C1908Q57003103-97B77737-C319-4C67-B4B2-A5CC2D6F2A48Q58555325-9FF14E8B-EFE2-4C5E-A459-A176C70DE914
P2860
CATNAP: a tool to compile, analyze and tally neutralizing antibody panels
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
CATNAP: a tool to compile, analyze and tally neutralizing antibody panels
@ast
CATNAP: a tool to compile, analyze and tally neutralizing antibody panels
@en
type
label
CATNAP: a tool to compile, analyze and tally neutralizing antibody panels
@ast
CATNAP: a tool to compile, analyze and tally neutralizing antibody panels
@en
prefLabel
CATNAP: a tool to compile, analyze and tally neutralizing antibody panels
@ast
CATNAP: a tool to compile, analyze and tally neutralizing antibody panels
@en
P2093
P2860
P50
P356
P1476
CATNAP: a tool to compile, analyze and tally neutralizing antibody panels
@en
P2093
Anthony P West
Hyejin Yoon
Jennifer Macke
Karina Yusim
P2860
P304
P356
10.1093/NAR/GKV404
P407
P577
2015-06-04T00:00:00Z